These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20731046)

  • 21. Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model.
    Jäger R; Werling U; Rimpf S; Jacob A; Schorle H
    Mol Cancer Res; 2003 Oct; 1(12):921-9. PubMed ID: 14573793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activating enhancer binding protein 2 epsilon (AP-2ε)-deficient mice exhibit increased matrix metalloproteinase 13 expression and progressive osteoarthritis development.
    Niebler S; Schubert T; Hunziker EB; Bosserhoff AK
    Arthritis Res Ther; 2015 May; 17(1):119. PubMed ID: 25964075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes.
    Wenke AK; Grässel S; Moser M; Bosserhoff AK
    FEBS J; 2009 May; 276(9):2494-504. PubMed ID: 19476490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
    Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
    J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of AP-2 transcription factors in the regulation of cartilage and skeletal development.
    Wenke AK; Bosserhoff AK
    FEBS J; 2010 Feb; 277(4):894-902. PubMed ID: 20050923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
    Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
    Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the HMOX1 gene by the transcription factor AP-2δ with unique DNA binding site.
    Sun L; Zhao Y; Gu S; Mao Y; Ji C; Xin X
    Mol Med Rep; 2014 Jul; 10(1):423-8. PubMed ID: 24789576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-Inducible Factor 1 Is an Inductor of Transcription Factor Activating Protein 2 Epsilon Expression during Chondrogenic Differentiation.
    Niebler S; Angele P; Kujat R; Bosserhoff AK
    Biomed Res Int; 2015; 2015():380590. PubMed ID: 26273614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells.
    Li H; Goswami PC; Domann FE
    Neoplasia; 2006 Jul; 8(7):568-77. PubMed ID: 16867219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
    Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
    Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription.
    Beger M; Butz K; Denk C; Williams T; Hurst HC; Hoppe-Seyler F
    J Mol Med (Berl); 2001 Jun; 79(5-6):314-20. PubMed ID: 11485026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The AP-2alpha transcription factor regulates tumor cell migration and apoptosis.
    Orso F; Fassetta M; Penna E; Solero A; De Filippo K; Sismondi P; De Bortoli M; Taverna D
    Adv Exp Med Biol; 2007; 604():87-95. PubMed ID: 17695722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.
    Melnikova VO; Dobroff AS; Zigler M; Villares GJ; Braeuer RR; Wang H; Huang L; Bar-Eli M
    PLoS One; 2010 Aug; 5(8):e12452. PubMed ID: 20805990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AP-2γ Is Required for Maintenance of Multipotent Mammary Stem Cells.
    Gu VW; Cho E; Thompson DT; Cassady VC; Borcherding N; Koch KE; Wu VT; Lorenzen AW; van der Heide DM; White JR; Kulak MV; Williams T; Zhang W; Weigel RJ
    Stem Cell Reports; 2021 Jan; 16(1):106-119. PubMed ID: 33382976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties.
    Zhao F; Satoda M; Licht JD; Hayashizaki Y; Gelb BD
    J Biol Chem; 2001 Nov; 276(44):40755-60. PubMed ID: 11522791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AP-2δ is a crucial transcriptional regulator of the posterior midbrain.
    Hesse K; Vaupel K; Kurt S; Buettner R; Kirfel J; Moser M
    PLoS One; 2011; 6(8):e23483. PubMed ID: 21858141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.
    Orso F; Cottone E; Hasleton MD; Ibbitt JC; Sismondi P; Hurst HC; De Bortoli M
    Biochem J; 2004 Jan; 377(Pt 2):429-38. PubMed ID: 14565844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-200a inhibits tumor proliferation by targeting AP-2γ in neuroblastoma cells.
    Gao SL; Wang LZ; Liu HY; Liu DL; Xie LM; Zhang ZW
    Asian Pac J Cancer Prev; 2014; 15(11):4671-6. PubMed ID: 24969902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative TFAP2A isoforms have distinct activities in breast cancer.
    Berlato C; Chan KV; Price AM; Canosa M; Scibetta AG; Hurst HC
    Breast Cancer Res; 2011 Mar; 13(2):R23. PubMed ID: 21375726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of activator protein-2 isoforms in renal cell carcinoma.
    Oya M; Mikami S; Mizuno R; Miyajima A; Horiguchi Y; Nakashima J; Marumo K; Mukai M; Murai M
    Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.